vTv Therapeutics
VTVT
VTVT
41 hedge funds and large institutions have $20M invested in vTv Therapeutics in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
-3
Holders Change %
-6.82%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
GC
GMT Capital
Atlanta,
Georgia
|
+$3.82M |
2 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$1.2M |
3 |
RA
Royce & Associates
New York
|
+$562K |
4 |
![]()
JPMorgan Chase & Co
New York
|
+$478K |
5 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$399K |
Top Sellers
1 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.04M |
2 |
![]()
Alyeska Investment Group
Chicago,
Illinois
|
-$551K |
3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$541K |
4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$267K |
5 |
Renaissance Technologies
New York
|
-$144K |